Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Asthma Therapeutics Market Size, Status and Forecast 2020-2026

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Asthma Therapeutics Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Asthma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Inhalation
    • 1.4.3 Parenteral
    • 1.4.4 Oral
  • 1.5 Market by Application
    • 1.5.1 Global Asthma Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
  • 1.6 Coronavirus Disease 2019 (Covid-19): Asthma Therapeutics Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Asthma Therapeutics Industry
      • 1.6.1.1 Asthma Therapeutics Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Asthma Therapeutics Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Asthma Therapeutics Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Asthma Therapeutics Market Perspective (2015-2026)
  • 2.2 Asthma Therapeutics Growth Trends by Regions
    • 2.2.1 Asthma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Asthma Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Asthma Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Asthma Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Asthma Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Asthma Therapeutics Players by Market Size
    • 3.1.1 Global Top Asthma Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Asthma Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Asthma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Asthma Therapeutics Market Concentration Ratio
    • 3.2.1 Global Asthma Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Asthma Therapeutics Revenue in 2019
  • 3.3 Asthma Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Asthma Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Asthma Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Asthma Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Asthma Therapeutics Forecasted Market Size by Type (2021-2026)

5 Asthma Therapeutics Breakdown Data by Application (2015-2026)

  • 5.1 Global Asthma Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Asthma Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Asthma Therapeutics Market Size (2015-2020)
  • 6.2 Asthma Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Asthma Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Asthma Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Asthma Therapeutics Market Size (2015-2020)
  • 7.2 Asthma Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Asthma Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Asthma Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Asthma Therapeutics Market Size (2015-2020)
  • 8.2 Asthma Therapeutics Key Players in China (2019-2020)
  • 8.3 China Asthma Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Asthma Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Asthma Therapeutics Market Size (2015-2020)
  • 9.2 Asthma Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Asthma Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Asthma Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Asthma Therapeutics Market Size (2015-2020)
  • 10.2 Asthma Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Asthma Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Asthma Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Asthma Therapeutics Market Size (2015-2020)
  • 11.2 Asthma Therapeutics Key Players in India (2019-2020)
  • 11.3 India Asthma Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Asthma Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Asthma Therapeutics Market Size (2015-2020)
  • 12.2 Asthma Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Asthma Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Asthma Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 AstraZeneca
    • 13.1.1 AstraZeneca Company Details
    • 13.1.2 AstraZeneca Business Overview and Its Total Revenue
    • 13.1.3 AstraZeneca Asthma Therapeutics Introduction
    • 13.1.4 AstraZeneca Revenue in Asthma Therapeutics Business (2015-2020))
    • 13.1.5 AstraZeneca Recent Development
  • 13.2 Boehringer Ingelheim
    • 13.2.1 Boehringer Ingelheim Company Details
    • 13.2.2 Boehringer Ingelheim Business Overview and Its Total Revenue
    • 13.2.3 Boehringer Ingelheim Asthma Therapeutics Introduction
    • 13.2.4 Boehringer Ingelheim Revenue in Asthma Therapeutics Business (2015-2020)
    • 13.2.5 Boehringer Ingelheim Recent Development
  • 13.3 F. Hoffmann-La Roche
    • 13.3.1 F. Hoffmann-La Roche Company Details
    • 13.3.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
    • 13.3.3 F. Hoffmann-La Roche Asthma Therapeutics Introduction
    • 13.3.4 F. Hoffmann-La Roche Revenue in Asthma Therapeutics Business (2015-2020)
    • 13.3.5 F. Hoffmann-La Roche Recent Development
  • 13.4 GSK
    • 13.4.1 GSK Company Details
    • 13.4.2 GSK Business Overview and Its Total Revenue
    • 13.4.3 GSK Asthma Therapeutics Introduction
    • 13.4.4 GSK Revenue in Asthma Therapeutics Business (2015-2020)
    • 13.4.5 GSK Recent Development
  • 13.5 Merck
    • 13.5.1 Merck Company Details
    • 13.5.2 Merck Business Overview and Its Total Revenue
    • 13.5.3 Merck Asthma Therapeutics Introduction
    • 13.5.4 Merck Revenue in Asthma Therapeutics Business (2015-2020)
    • 13.5.5 Merck Recent Development
  • 13.6 Horizon Pharma
    • 13.6.1 Horizon Pharma Company Details
    • 13.6.2 Horizon Pharma Business Overview and Its Total Revenue
    • 13.6.3 Horizon Pharma Asthma Therapeutics Introduction
    • 13.6.4 Horizon Pharma Revenue in Asthma Therapeutics Business (2015-2020)
    • 13.6.5 Horizon Pharma Recent Development
  • 13.7 Mitsubishi Tanabe Pharma
    • 13.7.1 Mitsubishi Tanabe Pharma Company Details
    • 13.7.2 Mitsubishi Tanabe Pharma Business Overview and Its Total Revenue
    • 13.7.3 Mitsubishi Tanabe Pharma Asthma Therapeutics Introduction
    • 13.7.4 Mitsubishi Tanabe Pharma Revenue in Asthma Therapeutics Business (2015-2020)
    • 13.7.5 Mitsubishi Tanabe Pharma Recent Development
  • 13.8 Sanofi
    • 13.8.1 Sanofi Company Details
    • 13.8.2 Sanofi Business Overview and Its Total Revenue
    • 13.8.3 Sanofi Asthma Therapeutics Introduction
    • 13.8.4 Sanofi Revenue in Asthma Therapeutics Business (2015-2020)
    • 13.8.5 Sanofi Recent Development
  • 13.9 Mundipharma
    • 13.9.1 Mundipharma Company Details
    • 13.9.2 Mundipharma Business Overview and Its Total Revenue
    • 13.9.3 Mundipharma Asthma Therapeutics Introduction
    • 13.9.4 Mundipharma Revenue in Asthma Therapeutics Business (2015-2020)
    • 13.9.5 Mundipharma Recent Development
  • 13.10 Nycomed
    • 13.10.1 Nycomed Company Details
    • 13.10.2 Nycomed Business Overview and Its Total Revenue
    • 13.10.3 Nycomed Asthma Therapeutics Introduction
    • 13.10.4 Nycomed Revenue in Asthma Therapeutics Business (2015-2020)
    • 13.10.5 Nycomed Recent Development
  • 13.11 Kissei Pharmaceutical
    • 10.11.1 Kissei Pharmaceutical Company Details
    • 10.11.2 Kissei Pharmaceutical Business Overview and Its Total Revenue
    • 10.11.3 Kissei Pharmaceutical Asthma Therapeutics Introduction
    • 10.11.4 Kissei Pharmaceutical Revenue in Asthma Therapeutics Business (2015-2020)
    • 10.11.5 Kissei Pharmaceutical Recent Development
  • 13.12 ALK-Abello
    • 10.12.1 ALK-Abello Company Details
    • 10.12.2 ALK-Abello Business Overview and Its Total Revenue
    • 10.12.3 ALK-Abello Asthma Therapeutics Introduction
    • 10.12.4 ALK-Abello Revenue in Asthma Therapeutics Business (2015-2020)
    • 10.12.5 ALK-Abello Recent Development
  • 13.13 Array BioPharma
    • 10.13.1 Array BioPharma Company Details
    • 10.13.2 Array BioPharma Business Overview and Its Total Revenue
    • 10.13.3 Array BioPharma Asthma Therapeutics Introduction
    • 10.13.4 Array BioPharma Revenue in Asthma Therapeutics Business (2015-2020)
    • 10.13.5 Array BioPharma Recent Development
  • 13.14 SAMA Pharmaceuticals
    • 10.14.1 SAMA Pharmaceuticals Company Details
    • 10.14.2 SAMA Pharmaceuticals Business Overview and Its Total Revenue
    • 10.14.3 SAMA Pharmaceuticals Asthma Therapeutics Introduction
    • 10.14.4 SAMA Pharmaceuticals Revenue in Asthma Therapeutics Business (2015-2020)
    • 10.14.5 SAMA Pharmaceuticals Recent Development
  • 13.15 Whanin Pharmaceutical
    • 10.15.1 Whanin Pharmaceutical Company Details
    • 10.15.2 Whanin Pharmaceutical Business Overview and Its Total Revenue
    • 10.15.3 Whanin Pharmaceutical Asthma Therapeutics Introduction
    • 10.15.4 Whanin Pharmaceutical Revenue in Asthma Therapeutics Business (2015-2020)
    • 10.15.5 Whanin Pharmaceutical Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Asthma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Asthma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    AstraZeneca
    Boehringer Ingelheim
    F. Hoffmann-La Roche
    GSK
    Merck
    Horizon Pharma
    Mitsubishi Tanabe Pharma
    Sanofi
    Mundipharma
    Nycomed
    Kissei Pharmaceutical
    ALK-Abello
    Array BioPharma
    SAMA Pharmaceuticals
    Whanin Pharmaceutical

    Market segment by Type, the product can be split into
    Inhalation
    Parenteral
    Oral
    Market segment by Application, split into
    Hospitals
    Clinics

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Asthma Therapeutics status, future forecast, growth opportunity, key market and key players.
    To present the Asthma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Asthma Therapeutics are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now